These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3360051)

  • 21. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug interaction during multidrug regimens for treatment of leprosy.
    George J; Balakrishnan S; Bhatia VN
    Indian J Med Res; 1988 Feb; 87():151-6. PubMed ID: 3397146
    [No Abstract]   [Full Text] [Related]  

  • 23. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 24. Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy".
    Grosset JH; Baohang J; Noordeen SK
    Indian J Lepr; 1989 Jul; 61(3):323-7. PubMed ID: 2768880
    [No Abstract]   [Full Text] [Related]  

  • 25. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective study on seven years of multiple drug treatment for paucibacillary and multibacillary leprosy, in Bayara General Hospital, Nigeria.
    Blok LM; Bloos LJ; van den Berg G
    Lepr Rev; 1991 Jun; 62(2):193-200. PubMed ID: 1870382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and hematological side effects of clofazimine in leprosy patients.
    Costa Queiroz RH; de Souza AM; Sampaio SV; Melchior E
    Pharmacol Res; 2002 Aug; 46(2):191-4. PubMed ID: 12220960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial of two single-dose treatments for paucibacillary leprosy.
    Pattyn SR; Ghys P; Janssens L; Tshilumba K; Kuykens L; Karibushi N; Denis P
    Lepr Rev; 1994 Mar; 65(1):45-57. PubMed ID: 8201835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy.
    Reeve PA; Ala J; Hall JJ
    J Trop Med Hyg; 1992 Aug; 95(4):266-70. PubMed ID: 1386634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of dapsone on oral administration of Dapsomine--a comparative evaluation.
    Venkatesan K; Chauhan SL; Girdhar A; Girdhar BK
    Indian J Lepr; 1993; 65(2):157-61. PubMed ID: 8345229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
    Jamet P; Robin Y
    Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.
    Schalcher TR; Borges RS; Coleman MD; Batista Júnior J; Salgado CG; Vieira JL; Romão PR; Oliveira FR; Monteiro MC
    PLoS One; 2014; 9(1):e85712. PubMed ID: 24465659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of different regimens in multibacillary leprosy.
    Pattyn SR
    Lepr Rev; 1986; 57 Suppl 3():265-71. PubMed ID: 3553815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.